skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

22 Total results for product and free and sample content found

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Novartis Sees Reimbursement Advantage For PCSK9 Launch

28 Nov 2019

Administration under the medical benefit/Medicare Part B could mean easier reimbursement. The company outlined early plans for the launch of inclisiran after announcing it will buy The Medicines Company for $9.7bn.

Topic Business Strategies Deal trends Reimbursement

Medtech Insight: 世界の医療機器・医療技術の最新情報

Recipharm Boosts Inhalation And Injectables Manufacturing By Acquiring UK's Consort Medical

By Marion Webb 20 Nov 2019

Sweden's Recipharm has agreed to buy UK-based Consort Medical for £505m ($652m) to become a leading inhalation-device company and top five global CDMO.

Topic deal-trends

Generics Bulletin: ジェネリック&バイオシミラーニュース

Lupin Offloads Kyowa For $525m But Not Exiting Japan

By Vibha Ravi 13 Nov 2019

Lupin plans to invest in acquisitions and organic growth in the US and India after selling Japanese subsidiary Kyowa Pharma for an enterprise value of around $525m to Japan private equity group Unison Capital. But the Indian firm stresses it is not exiting Japan and will continue to look for marketing partnerships.

Topic deal-trends strategy

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

How Proximity Creates Partnerships

By William Looney 08 Nov 2019

Former Amgen R&D lead Sean Harper talks exclusively to In Vivo about his new role as a venture capitalist, joining veteran industry investor Beth Seidenberg as co-founder of Los Angeles-based Westlake Village BioPartners.

Topic business-strategies deal-trends

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Gene Therapy 'Vant' Unveiled As Dainippon, Roivant Finalise $3bn Deal

06 Nov 2019

Japanese firm signs definitive agreement to acquire Roivant's interests in five 'vants' initially, including new gene therapy operation, as ex-Genentech president named head of new entity.

Topic business-strategies deal-trends

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Ready, Set, Lowest: Who Won China's Latest Drug Bidding War?

18 Oct 2019

Ready, Set, Lowest: Who Won China's Latest Drug Bidding War?

Multinationals are feeling the heat to win in China's latest drug procurement battle. The winning prices have surprised even previous winners and may have a profound and long-lasting impact on the pharma sector.

Topic deal-trends strategy


MS Outlook 2020 Scrip 100

24 Jul 2019

Outlook 2020 is the annual look at the performance and future prospects of the global pharmaceutical industry. This year, the supplement will reach more people than ever before with distribution to In Vivo, Pink Sheet, Scrip, Medtech Insight and Generics bulletin subscribers PLUS events such as Biotech Showcase and Partnerships in Clinical Trials.

Topic deal-trends biopharmaceutical business-strategies

Pink Sheet: 世界の薬事規制と承認審査に関するニュース

The Drug Pricing Article Pack

15 Jul 2019

Get expert insights into the events driving drug pricing polices around the world.  This Article Pack covers drug pricing issues for: The EU - Vital developments for Norway, Denmark, and other EU countries, including the UK The US – Essential drug pricing info from a country where the issue has taken center stage Australia – Developments surrounding drug pricing issues in Australia

Topic deal-trends policy-and-regulation

Datamonitor Healthcare: 医療用医薬品の市場調査レポート


15 Jul 2019

無料ホワイトペーパー『2018年ベストセラー薬トップ10/原題:Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D(全24頁)』では、2018年(17年10月~18年9月)にグローバルで最も多くの売上を上げた医薬品トップ10に共通する要因や今後の課題について分析しています。

Topic drug-review strategy deal-trends





電話:+81 (0)3 6273 4260